Compare PIPR & OPCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PIPR | OPCH |
|---|---|---|
| Founded | 1895 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical/Nursing Services |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 3.5B |
| IPO Year | 2003 | 1996 |
| Metric | PIPR | OPCH |
|---|---|---|
| Price | $76.96 | $23.64 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $91.38 | $36.57 |
| AVG Volume (30 Days) | 433.4K | ★ 1.5M |
| Earning Date | 05-01-2026 | 04-30-2026 |
| Dividend Yield | ★ 2.26% | N/A |
| EPS Growth | ★ 54.49 | 3.25 |
| EPS | ★ 1.87 | 0.29 |
| Revenue | $1,904,217,000.00 | ★ $4,998,202,000.00 |
| Revenue This Year | $12.30 | $7.21 |
| Revenue Next Year | $13.55 | $8.55 |
| P/E Ratio | ★ $41.36 | $81.86 |
| Revenue Growth | ★ 24.33 | 16.17 |
| 52 Week Low | $69.16 | $18.01 |
| 52 Week High | $380.26 | $36.80 |
| Indicator | PIPR | OPCH |
|---|---|---|
| Relative Strength Index (RSI) | 55.67 | 53.32 |
| Support Level | $73.36 | $22.97 |
| Resistance Level | $78.53 | $24.83 |
| Average True Range (ATR) | 1.80 | 0.47 |
| MACD | 0.32 | -0.05 |
| Stochastic Oscillator | 79.12 | 56.12 |
Piper Sandler Cos is an investment bank and institutional securities firm, serving the needs of corporations, private equity groups, public entities, non-profit entities, and institutional investors in the United States (U.S.) and internationally. The company provides a broad set of products and services, including financial advisory services; equity and debt capital markets products; public finance services; institutional brokerage services; fundamental equity and macro research services; fixed income services; and alternative asset management strategies. It generates maximum revenue from Advisory services.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.